These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 4203142)
21. Specific chemotherapy of Chagas disease: controversies and advances. Urbina JA; Docampo R Trends Parasitol; 2003 Nov; 19(11):495-501. PubMed ID: 14580960 [No Abstract] [Full Text] [Related]
22. Design, structure-activity relationship and in vivo efficacy of piperazine analogues of fenarimol as inhibitors of Trypanosoma cruzi. Keenan M; Alexander PW; Diao H; Best WM; Khong A; Kerfoot M; Thompson RC; White KL; Shackleford DM; Ryan E; Gregg AD; Charman SA; von Geldern TW; Scandale I; Chatelain E Bioorg Med Chem; 2013 Apr; 21(7):1756-63. PubMed ID: 23462713 [TBL] [Abstract][Full Text] [Related]
23. Trypanocidal activity of extracts and fractions of Bertholletia excelsa. Campos FR; Januário AH; Rosas LV; Nascimento SK; Pereira PS; França SC; Cordeiro MS; Toldo MP; Albuquerque S Fitoterapia; 2005 Jan; 76(1):26-9. PubMed ID: 15664458 [TBL] [Abstract][Full Text] [Related]
35. Toward a novel metal-based chemotherapy against tropical diseases. 1. Enhancement of the efficacy of clotrimazole against Trypanosoma cruzi by complexation to ruthenium in RuCl2(clotrimazole)2. Sánchez-Delgado RA; Lazardi K; Rincón L; Urbina JA J Med Chem; 1993 Jul; 36(14):2041-3. PubMed ID: 8336342 [No Abstract] [Full Text] [Related]
36. Synthesis, biological evaluation, and structure-activity relationships of potent noncovalent and nonpeptidic cruzain inhibitors as anti-Trypanosoma cruzi agents. Ferreira RS; Dessoy MA; Pauli I; Souza ML; Krogh R; Sales AI; Oliva G; Dias LC; Andricopulo AD J Med Chem; 2014 Mar; 57(6):2380-92. PubMed ID: 24533839 [TBL] [Abstract][Full Text] [Related]
37. Parasitological cure of Chagas disease: is it possible? Is it relevant? Urbina JA Mem Inst Oswaldo Cruz; 1999; 94 Suppl 1():349-55. PubMed ID: 10677754 [No Abstract] [Full Text] [Related]
38. Trypanocidal activity of (-)-cubebin derivatives against free amastigote forms of Trypanosoma cruzi. de Souza VA; da Silva R; Pereira AC; Royo Vde A; Saraiva J; Montanheiro M; de Souza GH; da Silva Filho AA; Grando MD; Donate PM; Bastos JK; Albuquerque S; e Silva ML Bioorg Med Chem Lett; 2005 Jan; 15(2):303-7. PubMed ID: 15603944 [TBL] [Abstract][Full Text] [Related]
39. Isoxazolylnaphthoquinone effects on the growth of Trypanosoma cruzi. Amuchástegui PI; Moretti ER; Basso B; Sperandeo N; de Bertorello MM Rev Argent Microbiol; 1990; 22(4):199-207. PubMed ID: 2129475 [TBL] [Abstract][Full Text] [Related]
40. Trypanosoma cruzi: in vitro and in vivo antiproliferative effects of epigallocatechin gallate (EGCg). Güida MC; Esteva MI; Camino A; Flawiá MM; Torres HN; Paveto C Exp Parasitol; 2007 Oct; 117(2):188-94. PubMed ID: 17673202 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]